Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ASPSCR1
REST API REST API
Homo sapiens
ASPSCR1 is differentially expressed in 167 experiments: 76 organism parts: liver, prostate, ... (74 more);, 132 disease states: normal, colorectal adenocarcinoma, ... (130 more);, 52 cell types 203 cell lines 36 compound treatments and 64 other conditions.
Synonyms UBXN9, UBXD9, ASPS, ASPL
Orthologs ASPSCR1 (1 of 2) (Danio rerio)   ASPSCR1 (2 of 2) (Danio rerio)   ASPSCR1 (Gallus gallus)   Aspscr1 (Mus musculus)   ENSBTAG00000004632 (Bos taurus)   Aspscr1 (Rattus norvegicus)   CG33722 (Drosophila melanogaster)   aspscr1 (Xenopus laevis)   ENSBTAG00000047973 (Bos taurus)   ASPSCR1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term extrinsic to membrane, cytosol, vesicle membrane, protein binding, membrane, intracellular protein transport, glucose homeostasis, biological_process, molecular_function, microsome, peripheral to membrane of membrane fraction, cellular_component, perinuclear region of cytoplasm, internal side of plasma membrane, regulation of glucose import
InterPro Term UBX, TUG
UniProt Accession C9JAL9, Q9BZE9
Gene-Disease Assocation ALVEOLAR SOFT PART SARCOMA; ASPS
Search EB-eye ENSG00000169696
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-22541, E-MTAB-24, ... (16 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-2450, E-MTAB-62, ... (31 experiments)

Factor Value U/D Experiments
BT474
3
E-MEXP-440, E-MTAB-62, E-MTAB-37
SW480
1
2
E-MEXP-1014, E-GEOD-2509, E-MTAB-37
BCBL-1
1
E-GEOD-2149
THP-1
1
E-GEOD-24147
GM15510
1
E-GEOD-22639
UMC11
1
E-MTAB-37
197 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-21668, E-GEOD-20033, E-GEOD-3920, ... (21 experiments)

Factor Value U/D Experiments
testis - leydig cell
1
E-AFMX-5
immortalized cell culture
1
E-GEOD-14990
adipocyte
1
E-AFMX-5
epithelioid malignant mesothelioma (MM)
1
E-GEOD-21750
embryonic stem cell
1
E-MEXP-930
CD326negCD56+ cell
1
E-GEOD-21668
46 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-1869, E-GEOD-22148, E-GEOD-9692, ... (31 experiments)

Factor Value U/D Experiments
Emery-Dreifuss muscular dystrophy
2
E-MTAB-62, E-GEOD-3307
colon carcinoma
2
E-MTAB-37, E-MTAB-62
idiopathic dilated cardiomyopathy
1
E-GEOD-1145
ischemic cardiomyopathy
1
E-MTAB-62
esophageal adenocarcinoma
1
E-GEOD-1420
fibromatosis
1
E-MTAB-62
126 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-7400, E-GEOD-5258, E-GEOD-6907, E-GEOD-5741, ... (23 experiments)

Factor Value U/D Experiments
none
2
5
E-GEOD-5824, E-GEOD-1615, E-TABM-868, E-GEOD-7400, E-GEOD-20719, ... (7 experiments)
control
2
E-GEOD-3284, E-GEOD-4006
lipopolysaccharide
2
E-TABM-868, E-GEOD-3720
unknown
1
E-GEOD-7307
17beta-estradiol
4
1
E-GEOD-4006
1mM GDC-0941
1
E-GEOD-20719
30 more value(s).


BioSourceProvider

studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Factor Value U/D Experiments
Coriell: GM11830
1
E-GEOD-19519
Coriell: GM14468
1
E-GEOD-19519
Coriell: GM14452
1
E-GEOD-19519
Coriell: GM14480
1
E-GEOD-19519
Coriell: GM14409
1
E-GEOD-19519
Coriell: GM14475
1
E-GEOD-19519
17 more value(s).


Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd3
studied in E-GEOD-22601

cd34
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-20033, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22541, E-GEOD-2509, E-GEOD-19665 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MEXP-1482, E-GEOD-7578

Genotype
studied in E-TABM-763, E-TABM-36, E-GEOD-22593, E-TABM-868, E-GEOD-17347 ... (5 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-MEXP-2146

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-666, E-GEOD-16363, E-MEXP-935, ... (14 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, ... (6 experiments)

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Localisation of metastases
studied in E-GEOD-22541

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Performer
studied in E-GEOD-2004, E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-21750

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445

Replicate
studied in E-GEOD-18791

RNAi
studied in E-MEXP-1422, E-GEOD-12438, E-MEXP-101, E-GEOD-3697

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-1643, E-GEOD-19743, E-GEOD-7307

Stimulation
studied in E-GEOD-11428

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-19246, E-GEOD-13818

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-22541, E-GEOD-1561

Vehicle
studied in E-GEOD-5258

Processing time: 0.272 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM